摘要
冠状动脉疾病(Coronary artery disease, CAD)在全球范围内都是发病率和死亡率均较高的心血管疾病,鉴于此,寻找一条经济、可靠,方便的诊断和预测指标尤为必要,炎症反应是导致动脉粥样硬化的病理因素。近来,炎症生物标志物正在被深入研究,在最近的研究中,一种新的炎症反应指标,C反应蛋白/白蛋白(CAR),被证明是一种中等价值的动脉粥样硬化标志物,因为它能够确定CAD患者的严重程度和预后价值。本文综述主要阐明CAR对冠状动脉疾病的相关研究现状。
Coronary artery disease (CAD) is a cardiovascular disease with high incidence rate and mortality worldwide. In view of this, it is particularly necessary to find an economic, reliable and convenient diagnostic and predictive indicator. Inflammatory reaction is a pathological factor leading to ather-osclerosis. Recently, inflammatory biomarkers are being further studied. In recent studies, a new inflammatory response indicator, C-reactive protein/albumin (CAR), has proved to be a moderately valuable atherosclerosis marker because it can determine the severity and prognostic value of CAD patients. This review focuses on clarifying the current research status of CAR related to coronary artery disease.
出处
《临床医学进展》
2023年第4期6893-6898,共6页
Advances in Clinical Medicine
